Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- artículu científicu espublizáu en mayu de 2020 (ast)
- scientific article published on 02 May 2020 (en)
- наукова стаття, опублікована 2 травня 2020 (uk)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Francesco Bertolini
- Corrado Tarella
- Federica Gigli
- Rocco Pastano
- Simona Sammassimo
- Elisabetta Todisco
- Chiara Camisaschi
- Safaa Ramadan
|
rdfs:label
| - Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (en)
- Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (nl)
|
skos:prefLabel
| - Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (en)
- Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (nl)
|
name
| - Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (en)
- Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (nl)
|
author
| |
author
| |
title
| |
title
| - Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
DOI
| |
DOI
| |
DOI
| - 10.1080/10428194.2020.1759049
|
is about
of | |